FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting

June 28, 2022

At a previous Vaccines and Related Biological Products Advisory (VRBPAC) meeting on April 6, 2022, the committee discussed considerations that should inform strain composition decisions to ensure that available COVID-19 vaccines continue to meet public health needs, when and how frequently to consider strain composition changes, and the process that should be used for making a recommendation for updating the vaccine strain composition.

As a follow-up to the April 6th VRBPAC discussion, this June 28th, 2022 VRBPAC meeting is being held to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified.

Latest articles

Carolyn Beans How “forever chemicals” might impair the immune system Stain-resistant carpets...
Harold E. Buttram, Susan Kreider and Alan R. Yurko The writers of...
Carla Peeters A lingering disorder that can last for months or years...
el gato malo … the CDC just dramatically changed their claims about...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Stay up to date

Sign up to our newsletter to get the latest health-related news and events delivered straight to your inbox.

Become a CHA member

Become an active value-added member and trusted provider of medical and healthcare information and education by joining the CHA Membership Program.

Your donation helps us stand up for healthcare choice!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!